Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Oct;50(1):189–197.

Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.

Y Inada, M Kamiyama, T Kanemitsu, C L Hyman, W S Clark
PMCID: PMC1536856  PMID: 6216998

Abstract

Human erythrocytes (E) have surface receptors for the third component of complement (C3b-IA receptors) which mediate immune adherence haemagglutination (IAHA). We have observed that E from patients with systemic lupus erythematosus had imparied or defective C3b receptor (C3b-R) activity when circulating immune complexes (CIC) were found in serum. This phenomenon has been investigated by a newly developed method involving competitive inhibition of IAHA in patients with immune complex diseases. IAHA involving sheep E coated with antibody and complement (EAC), and indicator human E was inhibited by lysates of E with normal C3b-R activity from healthy donors and a monkey. In contrast, the lysates of E from 95% of patients bearing CIC did not inhibit IAHA, which indicated such E had defective or impaired C3b-R activity. This phenomenon was supported by control studies in which IAHA was not inhibited by lysates of E with absent, inactivated or occupied C3b-R. In those patients, in whom CIC disappeared during immunosuppressive therapy, C3b-R activity slowly returned to normal levels. Moreover, it was observed that C3b-R activity of patients' E decreased with the reappearance of CIC during exacerbations of disease. These observations suggest that CIC are carried in vivo by the C3b-R of E as well as those of the mononuclear phagocyte system, and that the E C3b-R may also contribute to the clearance of CIC.

Full text

PDF
189

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arend W. P., Mannik M. Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits. J Immunol. 1971 Jul;107(1):63–75. [PubMed] [Google Scholar]
  2. Dierich M. P., Bokisch V. A. Receptor-binding sites on C3 and C3b. J Immunol. 1977 Jun;118(6):2145–2150. [PubMed] [Google Scholar]
  3. Dierich M. P., Ferrone S., Pellegrino M. A., Reisfeld R. A. Chemical modulation of cell surfaces by sulfhydryl compounds: effect on C3b receptors. J Immunol. 1974 Sep;113(3):940–947. [PubMed] [Google Scholar]
  4. Ehlenberger A. G., Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med. 1977 Feb 1;145(2):357–371. doi: 10.1084/jem.145.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FINKELSTEIN A. E., KWOK G., HALL A. P., BAYLES T. B. The erythrocyte in rheumatoid arthritis. I. A method for the detection of an abnormal globulin coating. N Engl J Med. 1961 Feb 9;264:270–273. doi: 10.1056/NEJM196102092640603. [DOI] [PubMed] [Google Scholar]
  6. Fearon D. T. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1971–1975. doi: 10.1073/pnas.75.4.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frank M. M., Hamburger M. I., Lawley T. J., Kimberly R. P., Plotz P. H. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med. 1979 Mar 8;300(10):518–523. doi: 10.1056/NEJM197903083001002. [DOI] [PubMed] [Google Scholar]
  8. Gilliland B. C., Leddy J. P., Vaughan J. H. The detection of cell-bound antibody on complement-coated human red cells. J Clin Invest. 1970 May;49(5):898–906. doi: 10.1172/JCI106309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gluckman J. C., Beaufils H., Sanchez F. Inhibition of complement-dependent lymphocyte rosette formation by sera of patients with chronic glomerulonephritis. Clin Exp Immunol. 1976 Nov;26(2):247–252. [PMC free article] [PubMed] [Google Scholar]
  10. Haakenstad A. O., Mannik M. Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol. 1974 May;112(5):1939–1948. [PubMed] [Google Scholar]
  11. Inada Y., Kamiyama M., Kanemitsu T., Clark W. S. Detection of circulating immune complexes: a new application of immune adherence haemagglutination. Ann Immunol (Paris) 1981 Mar-Apr;132C(2):181–190. doi: 10.1016/0769-2625(81)90026-x. [DOI] [PubMed] [Google Scholar]
  12. Jaffe C. J., Vierling J. M., Jones E. A., Lawley T. J., Frank M. M. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest. 1978 Nov;62(5):1069–1077. doi: 10.1172/JCI109212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lockwood C. M., Worlledge S., Nicholas A., Cotton C., Peters D. K. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med. 1979 Mar 8;300(10):524–530. doi: 10.1056/NEJM197903083001003. [DOI] [PubMed] [Google Scholar]
  14. Mannik M., Arend M. P., Hall A. P., Gilliland B. C. Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med. 1971 Apr 1;133(4):713–739. doi: 10.1084/jem.133.4.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mannik M., Arend W. P. Fate of preformed immune complexes in rabbits and rhesus monkeys. J Exp Med. 1971 Sep 1;134(3 Pt 2):19s–31s. [PubMed] [Google Scholar]
  16. Mannik M. Physicochemical and functional relationships of immune complexes. J Invest Dermatol. 1980 May;74(5):333–338. doi: 10.1111/1523-1747.ep12543582. [DOI] [PubMed] [Google Scholar]
  17. Miyakawa Y., Yamada A., Kosaka K., Tsuda F., Kosugi E., Mayumi M. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet. 1981 Sep 5;2(8245):493–497. doi: 10.1016/s0140-6736(81)90882-5. [DOI] [PubMed] [Google Scholar]
  18. NELSON R. A., Jr The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science. 1953 Dec 18;118(3077):733–737. doi: 10.1126/science.118.3077.733. [DOI] [PubMed] [Google Scholar]
  19. Nakai H., Morito T., Tanimoto K., Horiuchi Y. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids. J Rheumatol. 1977 Winter;4(4):405–413. [PubMed] [Google Scholar]
  20. Nydegger U. E., Lambert P. H., Gerber H., Miescher P. A. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest. 1974 Aug;54(2):297–309. doi: 10.1172/JCI107765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ross G. D., Winchester R. J., Rabellino E. M., Hoffman T. Surface markers of complement receptor lymphocytes. J Clin Invest. 1978 Nov;62(5):1086–1092. doi: 10.1172/JCI109214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rothman I. K., Gelfand J. A., Fauci A. S., Frank M. M. The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors. J Immunol. 1975 Nov;115(5):1312–1315. [PubMed] [Google Scholar]
  23. Scornik J. C., Drewinko B. Receptors for IgG and complement in human spleen lymphoid cells. Preferential binding of particulate immune complexes through complement receptors. J Immunol. 1975 Nov;115(5):1223–1226. [PubMed] [Google Scholar]
  24. Scribner D. J., Fahrney D. Neutrophil receptors for IgG and complement: their roles in the attachment and ingestion phases of phagocytosis. J Immunol. 1976 Apr;116(4):892–897. [PubMed] [Google Scholar]
  25. Siegel I., Liu T. L., Gleicher N. The red-cell immune system. Lancet. 1981 Sep 12;2(8246):556–559. doi: 10.1016/s0140-6736(81)90941-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES